Literature DB >> 28149566

Utility of thrombophilia testing in patients with venous thrombo-embolism.

Masataka Kudo1, Huang L Lee2, Ian A Yang1, Philip J Masel1.   

Abstract

BACKGROUND: Clinical practice of thrombophilia testing those with venous thrombo-embolism (VTE) in public hospitals may not be consistent with the international guidelines. This study aims to assess whether practice of thrombophilia testing in two public hospitals are consistent with international guidelines, and to assess whether certain groups of patients were more likely to benefit from testing.
METHODS: A retrospective audit on patients who presented to two Queensland public hospitals from August 2011 to September 2012 with VTE. Data were collected on demographics, yield of the test, and whether the result of the test changed the duration of anticoagulation. Group analysis was performed to identify patients who were more likely to yield positive results.
RESULTS: Of the 152 patients, 49% were tested for thrombophilia, of whom 31% returned a positive result. 38% of patients with provoked VTE were tested for thrombophilia, inconsistent with guideline recommendations. In 1.2% of cases there were documented changes to duration of anticoagulation with positive results. The rates of positive results were 45% in unprovoked VTE cases compared with 29% in provoked VTE cases (P=0.054). The rates of positive results were 52% in recurrent VTE cases compared with 27% in those cases with first episode of VTE (P=0.007).
CONCLUSIONS: The practice of thrombophilia testing in public hospitals was frequently inconsistent with guidelines, and did not significantly influence clinical decisions. There was higher yield of testing in patients with recurrent episodes of VTE and possibly in patients with unprovoked VTE.

Entities:  

Keywords:  Thrombophilia; deep vein thrombosis; pulmonary embolism

Year:  2016        PMID: 28149566      PMCID: PMC5227200          DOI: 10.21037/jtd.2016.12.40

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

Review 1.  American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.

Authors:  Jack Hirsh; Valentin Fuster; Jack Ansell; Jonathan L Halperin
Journal:  Circulation       Date:  2003-04-01       Impact factor: 29.690

2.  Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Authors:  Willem M Lijfering; Saskia Middeldorp; Nic J G M Veeger; Karly Hamulyák; Martin H Prins; Harry R Büller; Jan van der Meer
Journal:  Circulation       Date:  2010-04-05       Impact factor: 29.690

3.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Reducing inpatient heritable thrombophilia testing using a clinical decision-making tool.

Authors:  Tyler W Smith; David Pi; Monika Hudoba; Agnes Y Y Lee
Journal:  J Clin Pathol       Date:  2013-10-29       Impact factor: 3.411

Review 5.  Diagnosis and management of heritable thrombophilias.

Authors:  Peter MacCallum; Louise Bowles; David Keeling
Journal:  BMJ       Date:  2014-07-17

Review 6.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

7.  NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing.

Authors:  Luke S Howard; Rodney J Hughes
Journal:  Thorax       Date:  2012-12-12       Impact factor: 9.139

8.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Authors:  Paolo Prandoni; Franco Noventa; Angelo Ghirarduzzi; Vittorio Pengo; Enrico Bernardi; Raffaele Pesavento; Matteo Iotti; Daniela Tormene; Paolo Simioni; Antonio Pagnan
Journal:  Haematologica       Date:  2007-02       Impact factor: 9.941

Review 9.  Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.

Authors:  Jodi B Segal; Daniel J Brotman; Alejandro J Necochea; Ashkan Emadi; Lipika Samal; Lisa M Wilson; Matthew T Crim; Eric B Bass
Journal:  JAMA       Date:  2009-06-17       Impact factor: 56.272

Review 10.  The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.

Authors:  Angela Tincani; Laura Andreoli; Cecilia Chighizola; Pier Luigi Meroni
Journal:  Autoimmunity       Date:  2009-05       Impact factor: 2.815

View more
  5 in total

1.  Requirement for a Pathologist's Second Signature Limits Inappropriate Inpatient Thrombophilia Testing.

Authors:  Jesse L Cox; Sara M Shunkwiler; Scott A Koepsell
Journal:  Lab Med       Date:  2017-11-08

2.  Patient experience and utility of genetic information: a cross-sectional study among patients tested for cancer susceptibility and thrombophilia.

Authors:  Elvira D'Andrea; Tyra Lagerberg; Corrado De Vito; Erica Pitini; Carolina Marzuillo; Azzurra Massimi; Maria Rosaria Vacchio; Paola Grammatico; Paolo Villari
Journal:  Eur J Hum Genet       Date:  2018-01-26       Impact factor: 4.246

3.  Appropriateness of thrombophilia testing in patients in the acute care setting and an evaluation of the associated costs.

Authors:  Riddhi Virparia; Luigi Brunetti; Stuart Vigdor; Christopher D Adams
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

4.  Current Knowledge on Factor V Leiden Mutation as a Risk Factor for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis.

Authors:  Daria Eppenberger; Henning Nilius; Betsy Anagnostelis; Carola A Huber; Michael Nagler
Journal:  Front Cardiovasc Med       Date:  2022-04-07

5.  Prevalence of thrombophilia-associated genetic risk factors in blood donors of a regional hospital in southern Brazil.

Authors:  Jéssica Dick-Guareschi; Juliana Cristine Fontana; Maria Teresa Vieira Sanseverino; Francyne Kubaski; Leo Sekine; Nanci Félix Mesquita; Tor Gunnar Hugo Onsten; Sandra Leistner-Segal
Journal:  Hematol Transfus Cell Ther       Date:  2021-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.